New test for type 2 diabetes found in Scotland

- Advertisement -

Europe UK (Commonwealth Union) – Type 2 diabetes continues to be a concerning issue across the UK with a significant proportion of the population having the condition with increases in more younger populations in recent years.

A recent study has found that analyzing alterations in DNA in the blood may enhance the ability to predict an individual’s risk of developing type 2 diabetes within a decade.

Researchers viewed at the influence of these alterations with DNA methylation together with other risk factors in roughly fifteen thousand individuals in forecasting the chance of developing the condition years ahead of any symptoms forming.

The findings may bring about preventative measures implemented earlier, lowering the economic and health burden resulting from type 2 diabetes.

Methylation is a process that involves the addition of a methyl group (CH3) to a molecule, typically DNA, RNA, or proteins. In the context of DNA, methylation involves the addition of a methyl group to the cytosine base of a DNA molecule, typically at a CpG site (a cytosine base followed by a guanine base). This process is catalyzed by enzymes known as DNA methyltransferases.

Scientists from the University of Edinburgh observed that the including DNA methylation data together with the risk factors increased the precise nature of the prediction.

Over 4.9 million individuals live with diabetes in the UK, with 90% of those with type 2 diabetes.

Researchers utilized their results to make an estimation on the predictive performance using a hypothetical screening scenario of 10,000 individuals, where 1 in 3 individuals get type 2 diabetes in a 10-year period.

“It is promising that our findings were observed in the Scottish and German studies with both showing an improvement in prediction above and beyond commonly used risk factors. Delaying onset is important as diabetes is a risk factor for other common diseases, including dementias,” said Yipeng Cheng a PhD student, from the Centre for Genomic and Experimental Medicine at the University of Edinburgh.

A Personal Note from the Publisher" Small photo of you, with your signature beneath

A Personal Note from the Publisher

My dear friend, thank you for your time with us today. This site was built for you, the members of the Commonwealth Family, and nothing matters more to me than hearing your voice and feedback.

What did you make of this article? Did it inform you, challenge you, or leave you wanting more?

Please tell me. I read your replies personally and they help shape everything we publish.

With warmest wishes,
Hon. Nirj Deva
Founder and Publisher.

Free, always. We'll never sell your details.

Hot this week

AI Vision Automates the Supply Chain to Address Logistics and Packaging Disputes

Logistics and supply chain networks are the backbone of...

A US$3 Trillion Opportunity Beckons: Why Argentina’s Entry into Singapore’s Trade Pact Matters

SINGAPORE — 2 NOVEMBER 2026 What takes place when one...

Africa’s Next Food Crisis Could Begin with Water: Why Kenya Is Calling for a Continental Investment Push

NAIROBI, KENYA — 2 NOVEMBER 2026 Does Africa's next food...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories